Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00321
|
|||||
| Drug Name |
Uridine
|
|||||
| Synonyms |
1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione; AI3-52690; C9H12N2O6; CHEBI:16704; DRTQHJPVMGBUCF-XVFCMESISA-N; EINECS 200-407-5; MLS000069625; SMR000058222; UNII-WHI7HQ7H85; Uracil riboside; Uracil-1-beta-d-ribofuranoside; Urd; Uridin; WHI7HQ7H85; b-Uridine; beta-Uridine; d-uridine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Depression [ICD11: 6A8Z] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C9H12N2O6
|
|||||
| Canonical SMILES |
C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O
|
|||||
| InChI |
InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7-,8-/m1/s1
|
|||||
| InChIKey |
DRTQHJPVMGBUCF-XVFCMESISA-N
|
|||||
| CAS Number |
CAS 322-35-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 244.2 | Topological Polar Surface Area | 119 | ||
| Heavy Atom Count | 17 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
-2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103313732
, 103852268
, 104310914
, 117358157
, 117613647
, 118048883
, 12109174
, 123059964
, 124525105
, 124799625
, 124882993
, 126523145
, 14710325
, 14847540
, 15221017
, 24900434
, 24900638
, 24900640
, 26702452
, 26715956
, 26754144
, 29225043
, 3134852
, 3275
, 3593
, 3718411
, 46167442
, 46391419
, 46504323
, 48095962
, 49833656
, 50059626
, 56459453
, 57323128
, 584045
, 77021584
, 7891023
, 81044517
, 81092927
, 8139953
, 8144667
, 8153756
, 825827
, 85164984
, 85230753
, 87577750
, 88835504
, 92298506
, 99226784
, 99438033
|
|||||
| ChEBI ID |
ChEBI:16704
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | CNT1 | Transporter Info | Concentrative nucleoside transporter 1 | Substrate | [2] | |
| CNT2 | Transporter Info | Concentrative nucleoside transporter 2 | Substrate | [3] | ||
| References | ||||||
| 1 | Uridine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Electrophysiological recordings of CNT1 (SLC28A1) activity on Nanions SURFE2R N1. | |||||
| 3 | Transport of ribavirin across the rat and human placental barrier: Roles of nucleoside and ATP-binding cassette drug efflux transporters. Biochem Pharmacol. 2019 May;163:60-70. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.